aid: immune-path
accessModel:
  pricing: unknown
  onboarding: unknown
  trial: false
  try_now: false
  public: false
  label: Unknown
  confidence: low
  source: []
  generated: '2026-07-22'
  method: derived
image: https://kinlane-images.s3.amazonaws.com/shared/apis-json/icons/immune-path.png
name: immune-path
description: 'Immune-Path (Yidao Biotechnology (Suzhou) Co., Ltd. / 怡道生物) is a China-based
  vaccine biotechnology company founded in 2017 and headquartered in Suzhou. The company
  develops human vaccines across recombinant protein antigen, novel viral vector, and
  messenger RNA (mRNA) platforms, backed by its own vaccine adjuvant technology. Its clinical
  and preclinical pipeline includes a recombinant zoster (shingles) vaccine produced in CHO
  cells, a nine-valent recombinant HPV vaccine expressed in Pichia pastoris, a respiratory
  syncytial virus (RSV) vaccine, a therapeutic gastric cancer vaccine, and a COVID-19 vaccine.
  Immune-Path is a portfolio company of Qiming Venture Partners. It is a life-sciences drug
  developer with no public developer, API, or software surface; this profile is maintained
  as a company record in the API Evangelist network.'
url: https://raw.githubusercontent.com/api-evangelist/immune-path/refs/heads/main/apis.yml
x-type: company
x-source: vc-portfolio
x-backed-by:
- qiming
x-tier: stub
x-tier-reason: portfolio-lead
x-no-api-surface: true
specificationVersion: '0.20'
created: '2026-07-17'
modified: '2026-07-19'
tags:
- Company
- Biotechnology
- Vaccines
- Immunology
- Pharmaceuticals
- Life Sciences
- Drug Development
- mRNA
- Healthcare
- China
apis: []
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
common:
- type: Website
  url: https://immune-path.com
x-enrichment:
  date: '2026-07-19'
  status: backfilled
  pass: local-v1
  note: backfilled from .gitignore signal + verified work evidence